Comments
Loading...

Marker Therapeutics Inc (MRKR) Stock Price, Quote, News & History

MRKRNASDAQ
$1.43
-0.01-0.69%
At close: Feb 13, 4:00 PM EST
$1.50
0.074.90%
After Hours: Feb 13, 7:56 PM EST

Key Statistics

Open
$1.44
Close
$1.43
Volume / Avg.
135.07K / 389.61K
Day Range
$1.41 - $1.53
52 Wk Range
0.81 - 4.07
Market Cap
$25.01M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
3.72%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-14.82M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
24.76M
Free Cash Flow (TTM)
-14.82M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
9.94M

Analyst Trends and Forecast

1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$9.92M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.81
PB Ratio (TTM)
1.31
Earnings Yield % (TTM)
-80.69%
Earnings Yield % (FWD)
-66.90%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.10

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$17.59M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.44
Close
$1.43
Volume / Avg.
135.07K / 389.61K
Day Range
$1.41 - $1.53
52 Wk Range
0.81 - 4.07
Market Cap
$25.01M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
3.72%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MRKR
SER

FAQ

Q

How do I buy Marker Therapeutics (MRKR) stock?

A

You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Marker Therapeutics (MRKR) competitors?

Q

What is the forecast, or price target, for Marker Therapeutics (MRKR) stock?

A

Marker Therapeutics has a consensus price target of $12.38.

Q

What is the current price for Marker Therapeutics (MRKR)?

A

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.5 last updated February 13, 2026 at 7:56 PM EST.

Q

Does Marker Therapeutics (MRKR) pay a dividend?

A

There are no upcoming dividends for Marker Therapeutics.

Q

When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?

A

Marker Therapeutics does not have any upcoming earnings scheduled.

Q

Is Marker Therapeutics (MRKR) going to split?

A

There is no upcoming split for Marker Therapeutics.

Q

What sector and industry does Marker Therapeutics (MRKR) operate in?

A

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.